C-peptide as a marker of insulin requirement is commonly measured in patients with type 1 diabetes mellitus, but low endogenous insulin production commonly remains unchecked in most patients with type 2 diabetes mellitus [7]. This evidence concerns the gene INS and type 2 diabetes mellitus.